Back to results
US 12,697,326 B2Granted
Methods of treating hepatic encephalopathy
AssigneeSalix Pharmaceuticals, Inc.
InventorWilliam Forbes
Life of this patent
Estimating the term…
Abstract
The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin.
Claims3
A method of decreasing lactulose use in a hepatic encephalopathy subject, the method comprising:
- administering 550 mg rifaximin twice a day (BID) to the subject that is being treated with a baseline dosage of about 70 grams lactulose per day;
- and
- tapering lactulose consumption to a dosage of about 20 grams per day.
Dependencies are inferred from the claim text.